Comparison of clinical, familial, and MRI features of CADASIL and NOTCH3-negative patients

Neurology

Volumn 74, Issue 1, 2010, Pages 57-63

  Pantoni, L ^a   Pescini, F ^a   Nannucci, S ^a   Sarti, C ^a   Bianchi, S ^b   Dotti, M T ^b   Federico, A ^b   Inzitari, D ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; NOTCH3 RECEPTOR; NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CADASIL; CLINICAL FEATURE; FEMALE; GENE; GENE MUTATION; HUMAN; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEUROIMAGING; NOTCH3 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; TEMPORAL LOBE; BRAIN INFARCTION; COGNITIVE DEFECT; COMPARATIVE STUDY; EXON; FAMILY HEALTH; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BRAIN INFARCTION; CADASIL; COGNITION DISORDERS; DNA MUTATIONAL ANALYSIS; EXONS; FAMILY HEALTH; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MUTATION; RECEPTORS, NOTCH; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 74049102343     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181c7da7c     Document Type: Article

References (36)

1. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-710.
2. Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: a study of 7 families: cerebral autoso-mal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995;346:934-939.
3. Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731-739.
4. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 2004;127:2031-2038.
5. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 2004;127:2533-2539.
6. Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral au-tosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 1993;3:256-259.
7. Joutel A, Dodick DD, Parisi JE, Cecillon M, Tournier-Lasserve E, Bousser MG. De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol 2000;47:388-391.
8. Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology 1998;51:452-457.
9. Auer DP, Pütz B, Gössl C, Elbel G, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001;218:443-451.
10. Markus HS, Martin RJ, Simpson MA, et al. Diagnostic strategies in CADASIL. Neurology 2002;59:1134-1138.
11. Singhal S, Rich P, Markus HS. The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoen-cephalopathy and their relationship to age and clinical features. AJNR Am J Neuroradiol 2005;26:2481-2487.
12. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopa-thy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol 1995;89:500-512.
13. Mourad A, Levasseur M, Bousser MG, Chabriat H. CADASIL with minimal symptoms after 60 years. Rev Neurol 2006;162:827-831.
14. Pescini F, Bianchi S, Salvadori E, et al. A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient. J Neurol Sci 2008;267:170-173.
15. Ragoschke-Schumm A, Axer H, Fitzek C, et al. Intracere-bral haemorrhage in CADASIL. J Neurol Neurosurg Psychiatry 2005;76:1606-1607.
16. Feuerhake F, Volk B, Ostertag CB, et al. Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL. Acta Neuropathol 2002;103:188-192.
17. Schon F, Martin RJ, Prevett M, Clough C, Enevoldson TP, Markus HS. "CADASIL coma": an underdiagnosed acute encephalopathy. J Neurol Neurosurg Psychiatry 2003;74:249-252.
18. Rufa A, De Stefano N, Dotti MT, et al. Acute unilateral visual loss as the first symptom of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoen-cephalopathy. Arch Neurol 2004;61:577-580.
19. Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997;350:1511-1515.
20. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976;54: 541-553.
21. Ad hoc Committee established by the Advisory Council for the National Institute of Neurological and Communicative Disorders and Stroke. A classification and outline of cerebrovascular diseases II. Stroke 1975;6:564-616.
22. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:1-96.
23. Blume WT, Lüders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001;42:1212-1218. (Pubitemid 32951809)
24. World Health Organization. International Society of Hypertension Guidelines for the Management of Hypertension: Guidelines Subcommittee. J Hypertens 1999;17: 151-183.
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
26. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1333-1445.
27. Pantoni L, Basile AM, Pracucci G, et al. Impact of age-related cerebral white matter changes on the transition to disability: the LADIS study: rationale, design and methodology. Neuroepidemiology 2005;24:51-62.
28. Gouw AA, van der Flier WM, Pantoni L, et al. On the etiology of incident brain lacunes: longitudinal observations from the LADIS study. Stroke 2008;39:3083-3085.
29. Verreault S, Joutel A, Riant F, et al. A novel hereditary small vessel disease of the brain. Ann Neurol 2006;59: 353-357.
30. Hagel C, Groden C, Niemeyer R, Stavrou D, Colmant HJ. Subcortical angiopathic encephalopathy in a German kindred suggests an autosomal dominant disorder distinct from CADASIL. Acta Neuropathol 2004;108:231-240.
31. Hirabayashi S, Wada T, Kondo Y, Arima K. Autosomal dominant leukoencephalopathy with mild clinical symptoms due to cerebrovascular dysfunctions: a new disease entity? Brain Dev 2008;30:146-150.
32. Fouillade C, Chabriat H, Riant F, et al. Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain. Hum Mutat 2008;29:452-460.
33. Davous P. CADASIL: a review with proposed diagnostic criteria. Eur J Neurol 1998;5:219-233.
34. Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 1999;30:1230-1233.
35. Malandrini A, Gaudiano C, Gambelli S, et al. Diagnostic value of ultrastructural skin biopsy studies in CADASIL. Neurology 2007;68:1430-1432.
36. Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M. Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol 2005;62:1091-1094.